Research Focus

Former Employee. Immuno - Oncology Program; Non-Stipend SKI

Recent additions – View all

1. KIR3DL1/HLA-B subtypes govern acute myelogenous leukemia relapse after hematopoietic cell transplantation

   Journal Article

   Boudreau, J. E.; Giglio, F.; Gooley, T. A.; Stevenson, P. A.; Le Luduec, J. B.; Shaffer, B. C.; Rajalingam, R.; Hou, L.; Hurley, C. K.; Noreen, H.; more...
   Journal of Clinical Oncology (2017)

   Fulltext@MSK | Save
2. Donor KIR3DL1 and HLA-B allotypes control leukemia relapse after allogeneic hematopoietic stem cell transplantation

   Meeting Abstract

   Giglio, F.; Gooley, T. A.; Venstrom, J. M.; Gallagher, M. M.; Hou, L. H.; Hurley, C. K.; Lebedeva, T.; Noreen, H.; Rajalingam, R.; Reed, E. F.; more...
   Blood (2012)

   Fulltext@MSK | Save
3. KIR3DL1/S1 and HLA-B alleles combine to influence unrelated hematopoietic stem cell transplantation (HSCT) outcomes

   Meeting Abstract

   Giglio, F.; Venstrom, J. M.; Gooley, T. A.; Gallagher, M. M.; Lebedeva, T.; Noreen, H.; Rajalingam, R.; Reed, E. F.; Vierra-Green, C.; Yu, N.; more...
   Biology of Blood and Marrow Transplantation (2012)

   Fulltext@MSK | Save